Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-04-02 09:59 am Purchase | 13G | BAUDAX BIO INC BXRX | CVI Investments Inc. | 1,076,923 6.3% | 1,076,923 (New Position) | View |
| 2020-03-20 10:21 am Purchase | 13G | TILRAY BRANDS INC TLRY | CVI Investments Inc. | 10,084,845 9.9% | 10,084,845 (New Position) | View |
| 2020-03-20 10:02 am Purchase | 13G | KITOV PHARMA LTD SPONSORED ADR KTOV | CVI Investments Inc. | 4,057,219 9.9% | 4,057,219 (New Position) | View |
| 2020-03-06 09:25 am Purchase | 13G | COCRYSTAL PHARMA INC COCP | CVI Investments Inc. | 3,461,539 7.3% | 3,461,539 (New Position) | View |
| 2020-03-06 09:15 am Purchase | 13G | CELSION CORP COM PAR CLSN | CVI Investments Inc. | 1,571,429 5.6% | 1,571,429 (New Position) | View |
| 2020-02-28 09:33 am Purchase | 13G | ADAMIS PHARMACEUTICALS CORP CO ADMP | CVI Investments Inc. | 5,800,000 7.9% | 2,800,000 (+93.33%) | View |
| 2020-02-20 11:23 am Purchase | 13G | MYOMO INC MYO | CVI Investments Inc. | 225,634 9.9% | 225,634 (New Position) | View |
| 2020-02-14 09:03 am Purchase | 13G | TONIX PHARMACEUTICALS HLDG COR TNXP | CVI Investments Inc. | 1,242,515 9.9% | 1,131,265 (+1016.87%) | View |
| 2020-02-14 08:58 am Purchase | 13G | SALARIUS PHARMACEUTICALS INC SLRX | CVI Investments Inc. | 804,347 6.9% | 804,347 (New Position) | View |
| 2020-02-10 3:18 pm Unchanged | 13G | OPGEN INC PAR $0.01 OPGN | CVI Investments Inc. | 200,000 3.5% | 0 (Unchanged) | View |
| 2020-02-10 3:18 pm Purchase | 13G | PHIO PHARMACEUTICALS CORP COM PHIO | CVI Investments Inc. | 1,933,761 4.9% | 1,933,761 (New Position) | View |
| 2020-02-10 3:17 pm Sale | 13G | ORAGENICS INC OGEN | CVI Investments Inc. | 2,422,511 4.9% | -1,577,489 (-39.44%) | View |
| 2020-02-10 3:17 pm Purchase | 13G | RESHAPE LIFESCIENCES INC P RSLS | CVI Investments Inc. | 10,249 2.9% | 10,249 (New Position) | View |
| 2020-02-10 3:17 pm Sale | 13G | INSPIREMD INC PAR $0.0001 NSPR | CVI Investments Inc. | 10,000 0.3% | -90,000 (-90.00%) | View |
| 2020-02-10 3:17 pm Sale | 13G | SEELOS THERAPEUTICS INC SEEL | CVI Investments Inc. | 491,126 1.8% | -199,437 (-28.88%) | View |
| 2020-02-10 3:17 pm Sale | 13G | MANNKIND CORP MNKD | CVI Investments Inc. | 10,646,115 4.9% | -69,965 (-0.65%) | View |
| 2020-02-10 3:17 pm Sale | 13G | MOLECULIN BIOTECH INC MBRX | CVI Investments Inc. | 1,800,000 3.8% | -1,325,000 (-42.40%) | View |
| 2020-02-10 3:16 pm Sale | 13G | SESEN BIO INC SESN | CVI Investments Inc. | 5,497,845 4.9% | -3,682,155 (-40.11%) | View |
| 2020-02-10 3:16 pm Purchase | 13G | HEPION PHARMACEUTICALS INC HEPA | CVI Investments Inc. | 183,536 5% | 183,536 (New Position) | View |
| 2020-02-10 3:16 pm Sale | 13G | DELMAR PHARMACEUTICALS INC DMPI | CVI Investments Inc. | 599,131 4.9% | -75,869 (-11.24%) | View |